tirzepatide trial obesity without diabetes A 3-year study of in participants with and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to with tirzepatide, as compared with placebo. Full SURMOUNT-1 surmount-1 tirzepatide trial obesity without
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3






















